Literature DB >> 12237205

Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity.

Nora Hagelberg1, Ilkka K Martikainen, Heikki Mansikka, Susanna Hinkka, Kjell Någren, Jarmo Hietala, Harry Scheinin, Antti Pertovaara.   

Abstract

The pain modulatory role of dopamine D2 receptors of the human forebrain was studied by determining the association between dopamine D2 receptor binding potential and the response to experimental pain. Nineteen healthy male volunteers participated in a dopamine D2 receptor positron emission tomography study. The extrastriatal regions of interest studied with [11C]FLB 457 as radioligand (n = 11) were the anterior cingulum, the medial and lateral thalamus, the medial and lateral frontal cortex, and the medial and lateral temporal cortex. The striatal regions of interest studied with [11C]raclopride (n = 8) were the caudate nucleus and the putamen. The latency to the ice water-induced cold pain threshold and tolerance were determined in a separate psychophysical test session. Moreover, the cutaneous heat pain threshold and its elevation by concurrent cold pain in the contralateral hand were determined in each subject. Cold pain threshold was inversely correlated with D2 binding potential in the right putamen and the cold pain tolerance was inversely correlated with D2 binding potential in the right medial temporal cortex. The magnitude of heat pain threshold elevation induced by concurrent cold pain was directly correlated with D2 binding potential in the left putamen. Other correlations of D2 binding potentials in varying brain regions with sensory responses were not significant. A psychophysical control study (n = 10) showed that cold pain responses were identical in the right and left hand. The results indicate that dopamine D2 receptor binding potential in the human forebrain, particularly in the striatum, may be an important parameter in determining the individual cold pain response and the potential for central pain modulation. Accordingly, an individual with only few available D2 receptors in the forebrain is likely to have a high tonic level of pain suppression, combined with a low capacity to recruit more (dopaminergic) central pain inhibition by noxious conditioning stimulation. Copyright 2002 International Association for the Study of Pain

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237205     DOI: 10.1016/s0304-3959(02)00121-5

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  23 in total

Review 1.  Sex hormones and pain: the evidence from functional imaging.

Authors:  Katy Vincent; Irene Tracey
Journal:  Curr Pain Headache Rep       Date:  2010-10

Review 2.  The striatum and pain modulation.

Authors:  Ana C Barceló; Bárbara Filippini; Jorge H Pazo
Journal:  Cell Mol Neurobiol       Date:  2011-07-26       Impact factor: 5.046

3.  The contribution of the putamen to sensory aspects of pain: insights from structural connectivity and brain lesions.

Authors:  Christopher J Starr; Lumy Sawaki; George F Wittenberg; Jonathan H Burdette; Yoshitetsu Oshiro; Alexandre S Quevedo; John G McHaffie; Robert C Coghill
Journal:  Brain       Date:  2011-05-26       Impact factor: 13.501

Review 4.  Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction.

Authors:  Johanna M Jarcho; Emeran A Mayer; Ziyue Karen Jiang; Natasha A Feier; Edythe D London
Journal:  Pain       Date:  2012-03-03       Impact factor: 6.961

5.  Pain: novel analgesics from traditional Chinese medicines.

Authors:  Susan L Ingram
Journal:  Curr Biol       Date:  2014-02-03       Impact factor: 10.834

Review 6.  Psychiatry in chronic pain: a review and update.

Authors:  John Sharp; Brian Keefe
Journal:  Curr Psychiatry Rep       Date:  2005-06       Impact factor: 5.285

Review 7.  Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions.

Authors:  Amanda L-C Chen; Thomas J H Chen; Roger L Waite; Jeffrey Reinking; Howard L Tung; Patrick Rhoades; B William Downs; Eric Braverman; Dasha Braverman; Mallory Kerner; Seth H Blum; Nicholas DiNubile; David Smith; Marlene Oscar-Berman; Thomas J Prihoda; John B Floyd; David O'Brien; H H Liu; Kenneth Blum
Journal:  Med Hypotheses       Date:  2008-10-31       Impact factor: 1.538

8.  Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine.

Authors:  Eric H Chudler; Ying Lu
Journal:  Brain Res       Date:  2008-04-08       Impact factor: 3.252

Review 9.  Preclinical and early clinical investigations related to monoaminergic pain modulation.

Authors:  Kirsty Bannister; Lucy A Bee; Anthony H Dickenson
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Differential dopamine function in fibromyalgia.

Authors:  Daniel S Albrecht; Palmer J MacKie; David A Kareken; Gary D Hutchins; Evgeny J Chumin; Bradley T Christian; Karmen K Yoder
Journal:  Brain Imaging Behav       Date:  2016-09       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.